Micaela Owens
Neurology · Point Pleasant, WVNPI 1407351877
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 91 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AbbVie at 28.2% of the total. 2025 is the largest year on record at $1,098, 6.3 times the $175 reported in 2023.
Across 91 payments — averaging $18.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$462
- Biogen$356
- SK Life Science, Inc.$146
- Livanova USA, Inc.$130
- Lundbeck LLC$109
- UCB, Inc.$97
- plus $339 from 13 others
What the payments were for
- Food & beverage$1,639100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 29 | $462 |
| Biogen | 25 | $356 |
| SK Life Science, Inc. | 9 | $146 |
| Livanova USA, Inc. | 3 | $130 |
| Lundbeck LLC | 1 | $109 |
| UCB, Inc. | 5 | $97 |
| EMD Serono, Inc. | 3 | $46 |
| Neurelis, Inc. | 2 | $41 |
| Xeris Pharmaceuticals, Inc. | 2 | $39 |
| Medtronic | 2 | $35 |
| Novartis | 2 | $32 |
| Jazz Pharmaceuticals Inc. | 1 | $25 |
| Abbott | 1 | $22 |
| Lilly USA, LLC | 1 | $19 |
| Neurocrine Biosciences, Inc. | 1 | $18 |
| Philips North America LLC | 1 | $18 |
| Merz Pharmaceuticals, LLC | 1 | $18 |
| Grifols USA, LLC | 1 | $14 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VYEPTI$109
How this compares
$1,639 in reported general payments places this provider in the 55th percentile of 93 neurology providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Carbidopa-LevodopaCarbidopa/Levodopa | 113 | $2,038 |
| Gabapentin | 78 | $1,291 |
| Entacapone | 17 | $1,234 |
| Primidone | 14 | $902 |
| Lacosamide | 18 | $848 |
| Oxcarbazepine | 22 | $796 |
| Levetiracetam | 26 | $762 |
| Propranolol Hcl | 22 | $719 |
| RivastigmineRivastigmine Tartrate | 20 | $607 |
| Mirtazapine | 16 | $571 |
| Baclofen | 24 | $552 |
| Duloxetine Hcl | 34 | $531 |
| Donepezil Hcl | 63 | $388 |
| Topiramate | 60 | $369 |
| Amitriptyline Hcl | 39 | $364 |
Paid to pharmacies, not to this prescriber.
Other neurology in Point Pleasant
- Barry VaughtCrab Orchard$1.4M
- Paul FergusonHuntington$649K
- Umer NajibMorgantown$246K
- Muhammed Nasher-AlneamCharleston$73K
- Robert LewisHurricane$73K
- Lauren SeebergerCharleston$72K
- Cheryl SmithMorgantown$68K
- Mouhannad AzzouzMorgantown$40K
- Gregory MathewsCharleston$30K
- Ronald BareboHuntington$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.